These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19058784)

  • 1. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin.
    Fujitsuka N; Asakawa A; Hayashi M; Sameshima M; Amitani H; Kojima S; Fujimiya M; Inui A
    Biol Psychiatry; 2009 May; 65(9):748-59. PubMed ID: 19058784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphagia alters expression of hypothalamic 5-HT2C and 5-HT1B receptor genes and plasma des-acyl ghrelin levels in Ay mice.
    Nonogaki K; Nozue K; Oka Y
    Endocrinology; 2006 Dec; 147(12):5893-900. PubMed ID: 16973729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous ghrelin and 5-HT regulate interdigestive gastrointestinal contractions in conscious rats.
    Taniguchi H; Ariga H; Zheng J; Ludwig K; Mantyh C; Pappas TN; Takahashi T
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G403-11. PubMed ID: 18566321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
    Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
    Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
    Millan MJ; Veiga S; Girardon S; Brocco M
    Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prelimbic cortex 5-HT1A and 5-HT2C receptors are involved in the hypophagic effects caused by fluoxetine in fasted rats.
    Stanquini LA; Resstel LB; Corrêa FM; Joca SR; Scopinho AA
    Pharmacol Biochem Behav; 2015 Sep; 136():31-8. PubMed ID: 26143050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin family of peptides and gut motility.
    Asakawa A; Ataka K; Fujino K; Chen CY; Kato I; Fujimiya M; Inui A
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():73-4. PubMed ID: 21443714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors.
    Nonogaki K; Nozue K; Takahashi Y; Yamashita N; Hiraoka S; Kumano H; Kuboki T; Oka Y
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):675-81. PubMed ID: 16959056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
    Egashira N; Okuno R; Shirakawa A; Nagao M; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Biol Pharm Bull; 2012; 35(3):376-9. PubMed ID: 22382324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of 5-HT
    Tavares LRR; Baptista-de-Souza D; Canto-de-Souza A
    Neuropharmacology; 2018 Jun; 135():376-385. PubMed ID: 29548885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Sánchez C; Meier E
    Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats.
    Chen CY; Inui A; Asakawa A; Fujino K; Kato I; Chen CC; Ueno N; Fujimiya M
    Gastroenterology; 2005 Jul; 129(1):8-25. PubMed ID: 16012930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats.
    Fujino K; Inui A; Asakawa A; Kihara N; Fujimura M; Fujimiya M
    J Physiol; 2003 Jul; 550(Pt 1):227-40. PubMed ID: 12837928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal fluoxetine-evoked anxiety is prevented by concomitant 5-HT2A/C receptor blockade and mimicked by postnatal 5-HT2A/C receptor stimulation.
    Sarkar A; Chachra P; Vaidya VA
    Biol Psychiatry; 2014 Dec; 76(11):858-68. PubMed ID: 24315410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin and gastrointestinal movement.
    Fujitsuka N; Asakawa A; Amitani H; Fujimiya M; Inui A
    Methods Enzymol; 2012; 514():289-301. PubMed ID: 22975060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.